XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Cash Flows From Operating Activities:              
Net loss $ (8,320,549) $ (5,979,579) $ (682,187) $ (6,698,242) $ (14,300,128) $ (7,380,430)  
Adjustments to reconcile net loss to net cash flows used in operating activities:              
Depreciation and amortization 547,932   528,835   1,091,042 1,024,238  
Stock-based compensation         294,331 776,350  
Non-cash interest expense         576,380  
Change in fair value of warrant derivative liabilities 59,766   (5,413,618)   59,766 (5,561,789)  
Convertible debt discount amortization         925,455  
Loss on conversion of debt 93,386     93,386  
Provision for inventory obsolescence         (75,007) 192,622  
Provision for doubtful accounts receivable         24,140 (161,768)  
Allowance for doubtful lease reserve         5,000  
Change in fair value of contingent consideration promissory note         (158,021) (486,046)  
(Increase) decrease in:              
Accounts receivable – trade         155,015 721,540  
Accounts receivable – other         1,318,442 (776,216)  
Inventories         1,074,197 60,960  
Prepaid expenses         1,503,919 1,848,058  
Operating lease right of use assets         195,894 201,376  
Other assets         (2,092,524) (4,799,982)  
Increase (decrease) in:              
Accounts payable         3,066,137 1,994,602  
Accrued expenses         1,848,914 (73,127)  
Income taxes payable         (17,444) 9,969  
Lease deposit         10,445  
Operating lease obligations         (195,894) (201,375)  
Contract liabilities         1,486,569 1,678,503  
Net cash used in operating activities         (3,109,986) (10,932,515)  
Cash Flows from Investing Activities:              
Purchases of property, plant and equipment         (52,338) (1,923,501)  
Additions to intangible assets         (74,608) (54,866)  
Cash paid for acquisition of Medical Billing Company         (1,153,627)  
Cash paid for asset acquisition of Medical Billing Company         (230,000)  
Net cash used in investing activities         (126,946) (3,361,994)  
Cash Flows from Financing Activities:              
Repurchase and cancellation of common stock         (4,026,523)  
Distribution to noncontrolling interest in consolidated subsidiary         (15,692)  
Net proceeds of convertible debt with detachable warrants         2,640,000  
Proceeds – Commercial Extension of Credit – Entertainment Segment         1,000,000  
Payments on Commercial Extension of Credit – Entertainment Segment         (794,332)  
Principal payment on contingent consideration promissory notes         (217,054) (216,822)  
Net cash (used in) provided by financing activities         2,628,614 (4,259,037)  
Net decrease in cash and cash equivalents         (608,318) (18,553,546)  
Cash, cash equivalents, beginning of period   $ 3,532,199   $ 32,007,792 3,532,199 32,007,792 $ 32,007,792
Cash, cash equivalents, end of period $ 2,923,881   $ 13,454,246   2,923,881 13,454,246 $ 3,532,199
Supplemental disclosures of cash flow information:              
Cash payments for interest         18,129 27,059  
Cash payments for income taxes         8,097 9,969  
Supplemental disclosures of non-cash investing and financing activities:              
Commercial extension of credit repaid through accrued revenue – Entertainment segment         30,052  
ROU and lease liability recorded on extension of lease         538,056  
Conversion of convertible notes payable into common stock         119,750  
Issuance of contingent consideration promissory note for business acquired         855,000  
Assets acquired in business acquisitions         190,631  
Liabilities assumed in the business acquisition         387,005  
Goodwill acquired in business acquisitions         2,100,000  
Restricted common stock grant         35 36  
Reverse stock split rounding issuances         24  
Restricted common stock forfeitures         4 3  
Debt discount on convertible note         $ 3,000,000